Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 42

1.

3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions.

Bankson MG, Cunningham KA.

J Pharmacol Exp Ther. 2001 Jun;297(3):846-52. Review.

PMID:
11356903
[PubMed - indexed for MEDLINE]
Free Article
2.

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI.

Pharmacol Rev. 2003 Sep;55(3):463-508. Epub 2003 Jul 17. Review.

PMID:
12869661
[PubMed - indexed for MEDLINE]
Free Article
3.

Neuropharmacology and neurotoxicity of 3,4-methylenedioxymethamphetamine.

Gudelsky GA, Yamamoto BK.

Methods Mol Med. 2003;79:55-73. Review.

PMID:
12506690
[PubMed - indexed for MEDLINE]
4.

Interactions between 3,4-methylenedioxymethamphetamine and ethanol in humans and rodents.

Mohamed WM, Hamida SB, de Vasconcelos AP, Cassel JC, Jones BC.

Neuropsychobiology. 2009;60(3-4):188-94. doi: 10.1159/000253554. Epub 2009 Nov 5. Review.

PMID:
19893335
[PubMed - indexed for MEDLINE]
5.
6.

Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition.

de la Torre R, Farré M, Roset PN, Pizarro N, Abanades S, Segura M, Segura J, Camí J.

Ther Drug Monit. 2004 Apr;26(2):137-44. Review.

PMID:
15228154
[PubMed - indexed for MEDLINE]
7.

[3,4-methylenedioxymethamphetamine ('ecstasy'): its long-term emotional and cognitive effects, and serotonin depletion].

Molero-Chamizo A.

Rev Neurol. 2005 Jul 16-31;41(2):108-14. Review. Spanish.

PMID:
16028190
[PubMed - indexed for MEDLINE]
Free Article
8.

Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

Green AR, Cross AJ, Goodwin GM.

Psychopharmacology (Berl). 1995 Jun;119(3):247-60. Review.

PMID:
7675958
[PubMed - indexed for MEDLINE]
9.

Ecstasy: are animal data consistent between species and can they translate to humans?

Easton N, Marsden CA.

J Psychopharmacol. 2006 Mar;20(2):194-210. Review.

PMID:
16510478
[PubMed - indexed for MEDLINE]
10.

The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system.

White SR, Obradovic T, Imel KM, Wheaton MJ.

Prog Neurobiol. 1996 Aug;49(5):455-79. Review.

PMID:
8895996
[PubMed - indexed for MEDLINE]
11.

Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy').

Ricaurte GA, McCann UD, Szabo Z, Scheffel U.

Toxicol Lett. 2000 Mar 15;112-113:143-6. Review.

PMID:
10720723
[PubMed - indexed for MEDLINE]
12.

[Ecstasy--the status in French-speaking Switzerland. Composition of seized drugs, analysis of biological specimens and short review of its pharmacological action and toxicity].

Giroud C, Augsburger M, Sadeghipour F, Varesio E, Veuthey JL, Rivier L.

Praxis (Bern 1994). 1997 Mar 25;86(13):510-23. Review. French.

PMID:
9157497
[PubMed - indexed for MEDLINE]
13.

Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.

Colado MI, O'Shea E, Green AR.

Psychopharmacology (Berl). 2004 May;173(3-4):249-63. Epub 2004 Apr 9. Review.

PMID:
15083264
[PubMed - indexed for MEDLINE]
14.

3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans.

Steele TD, McCann UD, Ricaurte GA.

Addiction. 1994 May;89(5):539-51. Review.

PMID:
7913850
[PubMed - indexed for MEDLINE]
15.

Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons.

Gudelsky GA, Yamamoto BK.

Pharmacol Biochem Behav. 2008 Aug;90(2):198-207. Epub 2007 Oct 16. Review.

PMID:
18035407
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine.

Sprague JE, Everman SL, Nichols DE.

Neurotoxicology. 1998 Jun;19(3):427-41. Review.

PMID:
9621349
[PubMed - indexed for MEDLINE]
17.

[Ecstasy: psychostimulant, hallucinogen and toxic substance].

Burnat P, Le Brumant-Payen C, Huart B, Ceppa F, Pailler FM.

Presse Med. 1996 Sep 14;25(26):1208-12. Review. French.

PMID:
8949626
[PubMed - indexed for MEDLINE]
18.

Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction.

Seiden LS, Sabol KE.

NIDA Res Monogr. 1996;163:251-76. Review.

PMID:
8809863
[PubMed - indexed for MEDLINE]
19.

MDMA (3,4-Methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves.

Parrott AC.

Neuropsychobiology. 2004;50(4):329-35. Review.

PMID:
15539865
[PubMed - indexed for MEDLINE]
20.

The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA).

Cole JC, Sumnall HR.

Neurosci Biobehav Rev. 2003 May;27(3):199-217. Review.

PMID:
12788333
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk